Another step in improving the diagnosis of disseminated intravascular coagulation in sepsis

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Levi, Marcel ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; BLOOD CLOTTING TIME; DIAGNOSTIC PROCEDURE; DISSEMINATED INTRAVASCULAR CLOTTING; HYPERCOAGULABILITY; LABORATORY TEST; MORTALITY; NOTE; PRIORITY JOURNAL; PROTHROMBIN TIME; SCORING SYSTEM; SEPSIS; SURVIVOR; THROMBOCYTE COUNT; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMAN; MALE; MEDICAL SOCIETY; SEVERITY OF ILLNESS INDEX; STANDARDS;

DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MALE; SEPSIS; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL;

EID: 84887526725     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12859     Document Type: Note

References (14)

1. Gando S, Saitoh S, Ogura H, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Kushimoto S, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N. A multicenter prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 2013, 17:R111.
2. Taylor FBJ, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330.
3. Kim HK, Hong KH, Toh CH. Application of the international normalized ratio in the scoring system for disseminated intravascular coagulation. J Thromb Haemost 2010, 8:1116-1118.
4. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the international society of thrombosis and haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004, 32:2416-2421.
5. Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a five year overview. J Thromb Haemost 2007, 5:604-606.
6. Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol 2009, 22:129-136.
7. Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009, 23:167-176.
8. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson BR, Brandt JT, Sundin D, Levi M. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004, 2:1924-1933.
9. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592.
10. Levi M, van der Poll T, Schultz M. New insights into pathways that determine the link between infection and thrombosis. Neth J Med 2012, 70:114-120.
11. Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis 2010, 21:168-174.
12. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, Pusateri AE, Vos JA, Guymon CH, Wolf SE, Mann KG, Holcomb JB. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009, 67:266-275.
13. Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006, 135:220-227.
14. Tromp M, Tjan DH, van Zanten AR, Gielen-Wijffels SE, Goekoop GJ, van den Boogaard M, Wallenborg CM, Biemond-Moeniralam HS, Pickkers P. The effects of implementation of the Surviving Sepsis Campaign. Neth J Med 2011, 69:292-298.